Treatment of Chronic Constipation and Bleeding Anal Fissure

Part 1: Chronic Constipation

1. Lifestyle Modifications

• Adequate fluid intake - maintain good hydration throughout the day
• Regular, non-strenuous exercise - exercise increases propagated colonic contractions; sedentary patients are at much higher risk (relative risk of constipation in bed-bound patients is ~15x that of those who walk daily)
• Timed toilet training - attempt defecation for ~5 minutes at least twice daily, 30-60 minutes after a meal; never suppress the urge to defecate
• Optimal timing: the colon is most active in the first 2 hours after waking and after breakfast
• Yamada's Textbook of Gastroenterology, 7th Ed., p. 747-748

2. Diet and Fiber

• Target fiber intake of 20-30 g/day
• Psyllium (ispaghula husk) is the best-evidenced bulk-forming agent - Grade B recommendation from the American College of Gastroenterology; increases stool frequency by ~1.4 bowel movements/week
• Dried prunes were shown superior to psyllium in mild-to-moderate constipation
• Note: fiber supplements are less effective in slow-transit constipation or pelvic floor dysfunction
• Yamada's Textbook of Gastroenterology, 7th Ed., p. 748

3. Laxatives (Step-Up Approach)

4. Prescription Medications (for refractory cases)

• Lubiprostone (Amitiza) - chloride channel (ClC-2) activator; increases intestinal fluid secretion; approved for chronic idiopathic constipation and IBS-C
• Linaclotide (Linzess) - guanylate cyclase-C (GCC) receptor agonist; stimulates chloride/bicarbonate secretion; effective in RCTs for chronic constipation and IBS-C
• Plecanatide (Trulance) - also activates GCC receptors; two large RCTs confirmed efficacy at 3 mg daily for 12 weeks
• Prucalopride - selective 5-HT4 agonist (prokinetic); accelerates colonic transit; approved for chronic idiopathic constipation in women
• Yamada's Textbook of Gastroenterology, 7th Ed., p. 751-752

5. Treatment of Opioid-Induced Constipation

• Methylnaltrexone (subcutaneous or oral)
• Naloxegol (pegylated naloxone - does not cross blood-brain barrier)
• Naldemedine (Symproic)

6. Dyssynergic Defecation

• Biofeedback therapy is the primary treatment - instrument-based neuromuscular conditioning to restore coordinated defecation; has strong evidence
• Botulinum toxin injection into the puborectalis has limited efficacy
• Surgery is rarely indicated for this subtype

7. Slow-Transit Constipation

• Colonic manometry to identify colonic neuropathy
• Subtotal colectomy with ileorectal anastomosis - reserved for severe, refractory cases

Part 2: Anal Fissure (Acute + Chronic, with Bleeding)

• Sabiston Textbook of Surgery, 21st Ed., p. (block 23)

Conservative Measures (First for Acute Fissures)

1. Stool softening - the single most important step. Increase fluids + fiber + psyllium/methylcellulose + mild laxative (bisacodyl or docusate). Eliminate straining.
2. Sitz baths (warm water soaks, 10-15 min, 2-3x daily) - provide significant pain relief in >90% of patients with acute fissures and promote local vasodilation
3. Topical local anesthetics (lidocaine 2-5% ointment) - short-term pain relief, especially for acute fissures
4. Topical corticosteroids - reduce local inflammation; available as combination ointments/suppositories
5. Anal hygiene - gentle cleansing; avoid aggressive wiping

Specific First-Line Medical Therapy: Sphincter Relaxants

• Most widely used first-line agent
• Apply over the fissure after defecation and at bedtime; increase to 4x/day if needed
• Achieves pain relief in 60-70% at 4 weeks; healing in 45-60% at 3 months; 60-80% with repeat course
• Main side effect: headache in 30-40% of patients; 20-30% cannot tolerate it long-term (tachyphylaxis usually develops within 5-6 days)

• Preferred when GTN is not tolerated
• Apply twice daily up to 4x/day; pain relief at 4 weeks: 60-70%; healing at 3 months: 40-60%
• Virtually no headache side effects - better tolerability profile than GTN; similar efficacy
• Note: no commercial formulation available in the US - requires compounding pharmacy
• Sabiston Textbook of Surgery; Fischer's Mastery of Surgery, 8th Ed., p. 4238-4839

Specific Second-Line Medical Therapy: Botulinum Toxin Injection

• Inject 20-100 IU into the internal anal sphincter (intersphincteric plane, typically at 3 and 9 o'clock positions)
• Induces temporary sphincter paralysis lasting ~3 months
• Healing rates: 40-60% as second-line therapy; modest additional benefit after failed topical therapy
• Can be done in-office or as outpatient procedure with sedation
• Side effects: transient flatus incontinence (warn all patients), temporary increased urinary residual volume; hematoma/sepsis are uncommon

Surgical Treatment: Lateral Internal Sphincterotomy (LIS)

• Partial division of the internal anal sphincter (lower one-third), reducing resting anal tone
• Most effective treatment: healing rates >90% - significantly superior to all medical options
• Can be done open or closed technique, usually under local anesthesia as an outpatient
• Main risk: incontinence - minor fecal or flatus incontinence occurs in 0-30% depending on technique; permanent incontinence risk is ~1-2%
• Because of incontinence risk, surgery is not offered until at least first-line (and often second-line) medical therapy has been attempted first
• Women, elderly, and those with prior obstetric injuries are at higher risk for post-LIS incontinence
• Fischer's Mastery of Surgery, 8th Ed., p. 4845; Sabiston Textbook of Surgery

Summary: Stepwise Treatment Plan

STEP 1 (Both conditions simultaneously):
  - High-fiber diet (20-30g/day) + increased fluids
  - Psyllium or methylcellulose supplement
  - Stimulant/osmotic laxative (PEG, bisacodyl) to ensure soft stools
  - Sitz baths (3x daily)
  - Timed toilet training; never suppress defecation urge
  - Topical local anesthetic for pain PRN

STEP 2 (If fissure not healed in 4-8 weeks):
  - Add topical GTN 0.2% OR diltiazem 2% cream
  - Continue stool softening

STEP 3 (Refractory / 2nd-line):
  - Botulinum toxin injection (20-100 IU) into IAS
  - For constipation: escalate to linaclotide, prucalopride, or lubiprostone

STEP 4 (Surgical):
  - Lateral internal sphincterotomy (LIS) for chronic fissure unresponsive to above
  - Subtotal colectomy for severe refractory slow-transit constipation (rare)

• A 2024 network meta-analysis (PMID: 38693449) found probiotics, prebiotics, and synbiotics provide modest benefit as adjuncts to constipation therapy in adults.
• A 2025 systematic review (PMID: 39531948) confirmed abdominal massage as an effective non-pharmacological intervention for chronic constipation.
• A 2025 systematic review (PMID: 41493321) confirmed conservative approaches have comparable short-term outcomes to surgery for anal fissure, but surgery has superior long-term healing rates.

Important: All treatments listed here are clinical information for educational purposes. Patients should be evaluated individually - especially for alarm symptoms (weight loss, blood in stool, age >50, off-midline fissures) that warrant colonoscopy before assuming a benign cause.